Fundz

SynAct Pharma Appoints Ann Kristin Led as Chief Financial Officer

PRIVATEFeb 24, 2026

Position

Chief Financial Officer

Company

SynAct Pharma

Ann Kristin Led
LundBiotechnologyHealth Careresearch

Description

SynAct Pharma has announced the appointment of Ann Kristin Led as Chief Financial Officer, effective March 1, 2026. Ann Kristin is a seasoned financial executive with extensive experience in the life sciences and pharmaceutical sectors.

Quick answer

SynAct Pharma Appoints Ann Kristin Led as Chief Financial Officer (February 24, 2026). SynAct Pharma is based in Lund, Skåne County, Sweden.

Who is the new Chief Financial Officer at SynAct Pharma?
SynAct Pharma named Ann Kristin Led Chief Financial Officer, announced February 24, 2026.
What did SynAct Pharma announce on February 24, 2026?
SynAct Pharma has announced the appointment of Ann Kristin Led as Chief Financial Officer, effective March 1, 2026. Ann Kristin is a seasoned financial executive with extensive experience in the life sciences and pharmaceutical sectors.
What does SynAct Pharma do?
SynAct Pharma is a biotech company aiming at resolving inflammation by leveraging melanocortin biology.
Where is SynAct Pharma based?
SynAct Pharma is based in Lund, Skåne County, Sweden.
Which similar companies made leadership changes around the same time?
Arvinas (February 12, 2026), Grail (March 12, 2026), QuantHealth (March 24, 2026) and Target RWE (April 2, 2026) also announced leadership changes within 45 days of SynAct Pharma.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at SynAct Pharma, and when

A new leader at SynAct Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day SynAct Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SynAct Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SynAct Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SynAct Pharma

Location

2 Scheelevaegen

Lund, Skåne County, Sweden

About

SynAct Pharma is a biotech company aiming at resolving inflammation by leveraging melanocortin biology. Our lead asset AP1189 is in phase 2 development for the treatment of rheumatoid arthritis. AP1189 is an immunomodulatory small molecule delivered as a once-daily tablet. The mode of action is selective melanocortin receptor type 1 and 3 agonism, making it first-in-class. Activation of these receptors results in reduced secretion of proinflammatory cytokines by neutrophils and in conversion of macrophages towards clearing away cellular debris in hyper-inflamed tissue – two effects that together induce resolution of inflammation. The Phase 2a BEGIN study in patients with rheumatoid arthritis reported very promising efficacy and safety results in November 2021 - next step is to open an IND with FDA to get advice on further development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SynAct Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SynAct Pharma's next move

Learn about Strategic plan

SynAct Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.